ArticleAlzheimer's & dementia (New York, N. Y.)

Evaluation of amyloid change as a surrogate for cognitive decline: demonstration in individual-level data from the A4 study of solanezumab.

Sarah F Ackley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.